Reaction
Bile Duct Stent Insertion reporting signals
As of the last recalculation, Bile Duct Stent Insertion appears in 374 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is SITAGLIPTIN (PRR 184.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sitagliptin | 146 | 184.3 | 184.6 |
| Sitagliptin And Metformin Hydrochloride | 38 | 109.0 | 109.2 |
| Pancrelipase | 35 | 55.6 | 55.6 |
| Exenatide | 39 | 45.9 | 46.0 |